Immunogenicity & Safety of Bio Farma's Measles-Rubella (MR) Vaccine in Indonesian Infants (Bridging Study)

Conditions:   Congenital Rubella Infection;   Measles Interventions:   Biological: Measles-Rubella vaccine Bio Farma;   Biological: MR Vaccine SII Sponsor:   PT Bio Farma Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials